A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

Clinical trial NCT02615873 · UNKNOWN

Trial details

NCT number: NCT02615873
Sponsor: Intec Pharma Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2016-07-01
Primary completion: 2019-12-01
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.